Skip to main content
Clinical Trials/KCT0002229
KCT0002229
Not yet recruiting
未知

The influence of patient-clinician interaction context on acupuncture outcomes in functional dyspepsia - a randomized controlled international multi-center trial

Kyung Hee University Oriental Medical Center0 sites59 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyung Hee University Oriental Medical Center
Enrollment
59
Status
Not yet recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Kyung Hee University Oriental Medical Center

Eligibility Criteria

Inclusion Criteria

  • (1\) Age between 20 and 65 years
  • (2\) Meeting the definition of Functional Dyspepsia(FD) and Postprandial distress syndrome (PDS) as a subtype of Functional Dyspepsia according to the Rome III criteria
  • (3\) Complaints of a degree of dyspepsia more than 40 points on the visual analogue scale (VAS; 0, no symptom at all; 100, the most severe symptom one has ever had)
  • (4\) Individuals who agreed not to take any other new treatments associated with Functional Dyspepsia during the study
  • (5\) Individuals who voluntarily agreed and singed informed consent form

Exclusion Criteria

  • (1\) Have abnormal esophagogastroduodenoscopy results recently or evidence of any organic diseases affecting gastrointestinal tract (e.g. erosive esophagitis, peptic ulcer, dysplasia, mucosa\-associated, lymphoid tissue lymphoma, esophageal cancer, gastric cancer)
  • (2\) Individuals who have apparent signs of irritable bowel syndrome
  • (3\) Individuals who have alarmingsymptoms (weight loss, black or tarry stool, or dysphagia)
  • (4\) Individuals who have serious structural organ diseases (diseases of the heart, lung, liver, or kidney) or mental illness
  • (5\) Individuals who have undergone surgery related to the gastrointestinal tract (except for appendectomy performed for more than 6 months ago)
  • (6\) Individuals who are pregnant or breastfeeding
  • (7\) Individuals who are taking drugs that could affect the gastrointestinal tract ; a minimum wash\-out period of 2 weeks is required before participating in the trial.
  • (8\) Individuals who have participated other clinical trial within 1 month from the present
  • (9\) Individuals who are positive for human immunodeficiency virus infection
  • (10\) Individuals who are taking herbal medicine or oriental remedy that associated with dyspepsia / drugs that are considered inappropriate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Impact of doctor-patient participation in medical decision-making model on acupuncture combined with medicine for hearing rehabilitation in patients with sudden deafness
ITMCTR2000003476Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Completed
Not Applicable
Patient perception and clinical effectiveness of an allogeneic cortical sheet versus an autologous laminated bone graft for the treatment of horizontal bone defects
ISRCTN58672316ThinkingPerio Research - Periocentrum Bilbao15
Completed
Not Applicable
Application of patient communication software in conscious patients under mechanical ventilatioConscious patients under mechanical ventilation.Difficulty or need for assistance with communicationQF22
IRCT20220315054293N1Mashhad University of Medical Sciences60
Completed
Not Applicable
Involving medical companions in an explanation about switching to a biosimilar.Patients taking biologic medications (e.g. adalimumab, etanercept, infliximab, rituximab, tocilizumab) for rheumatic diseases.Patients taking biologic medications (e.g. adalimumab, etanercept, infliximab, rituximab, tocilizumab) for dermatological diseases.Decision makingInflammatory and Immune System - Rheumatoid arthritisSkin - Dermatological conditionsPublic Health - Health service research
ACTRN12619001435178Professor Keith Petrie79
Completed
Phase 2
Investigating the association between clinical and ocular characteristics with the outcomes of corneal collagen cross-linking (CXL)Keratoconus.KeratoconusH18.6
IRCT20131229015975N4Esfahan University of Medical Sciences85